Brookfield Corp’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-61,414
| Closed | -$5.59M | – | 137 |
|
|
2023
Q2 | $5.59M | Sell |
61,414
-54,726
| -47% | -$4.99M | 0.02% | 246 |
|
|
2023
Q1 | $7.66M | Buy |
116,140
+49,914
| +75% | +$3.29M | 0.03% | 212 |
|
|
2022
Q4 | $3.42M | Buy |
66,226
+5,996
| +10% | +$310K | 0.01% | 319 |
|
|
2022
Q3 | $4.11M | Buy |
60,230
+25,890
| +75% | +$1.77M | 0.02% | 298 |
|
|
2022
Q2 | $1.55M | Buy |
34,340
+19,474
| +131% | +$881K | 0.01% | 438 |
|
|
2022
Q1 | $755K | Buy |
+14,866
| New | +$755K | ﹤0.01% | 510 |
|